Skip to content
Medical Health Aged Care

Lucidis® Sets High Standards in Premium Cataract Surgery with Full-Range Vision Performance

SAV-IOL 2 mins read
NEUCHÂTEL, Switzerland--BUSINESS WIRE--

Swiss Advanced Vision announces new clinical evidence confirming the exceptional performance of its Lucidis® intraocular lens (IOL), strengthening its position as a disruptive solution in premium cataract surgery. Unlike traditional Extended Depth of Focus lenses, Lucidis® delivers full-range visual performance comparable to a premium trifocal IOL - while preserving contrast sensitivity, visual quality, and minimizing side effects such as halos and glare, hallmarks of its patented fully refractive design.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303823337/en/

Swiss Advanced Vision premium IOL lenses for cataract surgery

Swiss Advanced Vision premium IOL lenses for cataract surgery

A recent peer-reviewed study, Comparative Analysis of Visual Outcomes Between Lucidis 108M (EDOF) and PhysIOL BVI FineVision (Diffractive) IOLs Using Defocus Curve Measurements by H. Naftali, W. Nasser, and M. Naftali, provides compelling comparative data. The findings show that Lucidis® achieves a defocus curve remarkably close to that of a leading diffractive trifocal, demonstrating excellent distance, intermediate, and functional near vision. These results validate the unique optical concept behind Lucidis®, which combines a spherical monofocal base with the Instant Focus™ refractive element, engineered to extend the depth of focus and significantly reduce dysphotopsia.

Beyond the clinical outcomes highlighted in the Naftali study, the functional classification research led by Joaquin Fernandez, PhD, further positions Lucidis® distinctively within the category of full-range IOLs (FRoF). According to this work, Lucidis® provides consistent visual acuity at all distances - supporting surgeons seeking a premium solution that delivers high spectacle independence with high patient satisfaction.
Lucidis® is engineered and manufactured in Switzerland according to the highest precision standards. Its refractive design offers an alternative to multifocal technologies for patients who demand performance without compromise. With its mechanical stability in the capsular bag and consistently predictable refractive outcomes, Lucidis® is increasingly recognized as a premium reference in international markets.
“As the demand for spectacle independence grows, the need for advanced, reliable, and well-tolerated solutions becomes essential,” says Swiss Advanced Vision. “Lucidis® empowers surgeons to offer their patients a premium experience with confidence—full-range vision, visual quality, and an exceptional safety profile.”

If you’re an eyecare professional looking to save time and gain further clinical insights, now’s the perfect moment to join the Swiss Virtual Clinic on sav-iol.com!

Since 2009, SAV-IOL develops and markets advanced EDOF IOLs globally. Its LUCIDIS and EDEN lenses, powered by Instant Focus technology, provide continuous vision from near to intermediate and far distances.


Contact details:

Tel. +41 32 566 54 00 // [email protected]

Media

More from this category

  • Government Federal, Medical Health Aged Care
  • 06/03/2026
  • 06:00
Health Services Union

HSU urges federal government to make reproductive health leave a national employment standard

HSU urges federal government to make reproductive health leave a national employment standard The Health Services Union has used its submission to the Inquiry into the operation and adequacy of the National Employment Standard to argue for universal reproductive health leave. HSU, along with other unions, has been campaigning for 12 days of paid leave for reproductive health issues. The leave would cover speciality appointments and treatments relating to reproductive organs, including screenings for breast and prostate cancer, or the management of symptoms related to reproductive health, including periods, perimenopause, PCOS, endometriosis, vasectomy and hysterectomy, miscarriage and medical pregnancy terminations…

  • Medical Health Aged Care, Regional Country Services
  • 06/03/2026
  • 05:04
Council of Presidents of Medical Colleges

Medical colleges commit to national reform on specialist access and affordability for all Australians

For patients in regional and remote Australia, the specialist they need is too often simply not there. More than 80 per cent of Australia’s specialists practise in metropolitan areas, despite nearly a third of the population living outside the cities. Potentially preventable hospitalisations are 30 per cent higher in outer regional areas and 70 per cent higher in remote communities. At a two-day summit at Parliament House, Australia’s 16 specialist medical colleges have committed to working with state and Federal governments to reform how and where specialists are trained and have set new national standards on ethical billing and fee…

  • Medical Health Aged Care
  • 05/03/2026
  • 17:11
Galderma Group AG

Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency1, and Core EBITDA2 of 1.211 billion USD, Growing 18.9% at Constant Currency

Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland–BUSINESS WIRE– Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.